Circulating monoclonal B lymphocytes in multiple myeloma

Br J Haematol. 1989 May;72(1):28-31. doi: 10.1111/j.1365-2141.1989.tb07646.x.

Abstract

Peripheral blood mononuclear cells from 28 patients with multiple myeloma (MM) and nine patients with monoclonal gammopathy of unknown significance (MGUS) were studied by immunoglobulin gene analysis. Clonal immunoglobulin gene rearrangements in peripheral blood mononuclear cells (PBIGRA) were demonstrated in 10 of the 28 MM patients (36%). Bone marrow and peripheral blood mononuclear cells were studied simultaneously in five of these 10 patients, and identical gene rearrangements were demonstrated in both. The incidence of such gene arrangements was higher in patients with active disease (cases at presentation or relapsed = 10/19 [47%]) compared to remission status (0/9) and higher in untreated (47%) compared to treated patients (11%) (P less than 0.05). Patients with this phenomenon had higher serum calcium levels (P less than 0.001), and higher bone marrow plasma cell counts (P less than 0.05). Serum creatinine and beta 2-microglobulin were also higher but did not reach statistical significance. None of the patients with monoclonal gammopathy of uncertain significance had gene arrangements. Our findings confirm that circulating B lymphocytes are part of the malignant clone in MM and their presence correlates with high tumour volume.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • B-Lymphocytes*
  • Blotting, Southern
  • Gene Rearrangement, B-Lymphocyte
  • Genes, Immunoglobulin
  • Humans
  • Multiple Myeloma / blood*
  • Multiple Myeloma / genetics
  • Multiple Myeloma / immunology
  • Paraproteinemias / blood
  • Paraproteinemias / genetics
  • Paraproteinemias / immunology

Substances

  • Antibodies, Monoclonal